SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Nectar Lifescience Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
532649 INE023H01027 31.9661998 NECLIFE 0 390.66 0 0 1
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales5.876.15489.32
Other Operating Income0.710.011.79
Other Income 0.030.320.08
Total Income5.745.56430.77
Total Expenditure 181.7268.63585.00
PBIDT-175.98-63.07-154.23
Interest 0.000.0017.67
PBDT-175.98-63.07-171.90
Depreciation0.200.5315.77
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.18-0.37-57.58
Reported Profit After Tax-176.01-63.23-130.09
Extra-ordinary Items -175.68-62.550.00
Adjusted Profit After Extra-ordinary item-0.33-0.68-130.09
    
EPS (Unit Curr.)-7.84-2.82-5.80
EPS (Adj) (Unit Curr.)-7.84-2.82-5.80
Calculated EPS (Unit Curr.)-7.85-2.82-5.80
Calculated EPS (Adj) (Unit Curr.)-7.85-2.82-5.80
Calculated EPS (Ann.) (Unit Curr.)-31.39-11.28-23.20
Calculated EPS (Adj) (Ann.) (Unit Curr.)-31.39-11.28-23.20
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity22.4322.4322.43
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-3519.60-1205.93-35.96
PBDTM(%)-3519.60-1205.93-40.08
PATM(%)-3520.20-1208.99-30.33